Financial Results : Dallah H1 2025 profit up 21% to SAR 279.8M; Q2 at SAR 124.3M

Dallah H1 2025 profit up 21% to SAR 279.8M; Q2 at SAR 124.3M

04/08/2025 Argaam Exclusive

View other reports

Dallah Healthcare Co. reported a net profit of SAR 279.8 million in H1 2025, an increase of 21% from SAR 231.1 million a year earlier.



Financials (M)

Item 6m 2024 6m 2025 Change‬
Revenues 1,549.24 1,895.19 22.3 %
Gross Income 591.09 673.49 13.9 %
Operating Income 278.92 267.65 (4.0 %)
Net Income 231.14 279.82 21.1 %
Average Shares 97.68 101.57 4.0 %
Earnings Per Share before unusual items (Riyals) 2.37 2.13 (10.2 %)
EPS (Riyal) 2.37 2.75 16.4 %

The profit increase is driven by a 22.3% year-on-year (YoY) growth in revenue to SAR 1.89 billion. This was due to the record revenues achieved in the current quarter on improved operational capacity and strategic expansions in existing and acquired medical facilities. This contributed to the continued growth in the number of patients.

 

The acquisition of Al Salam Medical Services Co., owner of Dallah Hospital Al-Khobar, and Al Ahsa Medical Services Co., owner of Dallah Hospital Al-Ahsa, on March 23, 2025, had a positive impact on revenues. The total revenues of the two hospitals for the current period amounted to approximately SAR 189 million.

 

Dallah Hospital Al-Khobar and Dallah Hospital Al-Ahsa saw a surge in revenue under Dallah Health's management. The topline increased by 52% YoY (the hospitals' revenues for H1 2024 are not included in Dallah’s earnings as they preceded the acquisition date).

 

The acquisition of the two hospitals contributed a 37% increase in the group's bed capacity, with the addition of 424 beds (274 beds in Dallah Al-Ahsa Hospital and 150 beds in operation in Dallah Al-Khobar Hospital).

 

The deal is expected to increase the group's revenues by approximately SAR 500 million throughout 2025 (starting from the acquisition date of March 23, 2025). This growth is expected to continue at high rates in the following years, with increased operating rates at the two hospitals, particularly Dallah Hospital Al-Khobar.

 

The group's existing medical facilities prior to the acquisition also achieved revenue growth of SAR 157 million, a 10.1% increase YoY.

 

Following the acquisition of Dallah Hospital Al-Khobar, its net losses reduced by 49% YoY to SAR 23 million.

 

Net profit before interest, depreciation, amortization, and Zakat for the period rose by 21.3% to SAR 462 million, compared to SAR 381 million in the same period last year.



Current Quarter Comparison (M)

Compared With The
Item Q2 2024 Q2 2025 Change‬
Revenues 765.18 1,062.43 38.8 %
Gross Income 297.73 375.88 26.3 %
Operating Income 135.70 147.71 8.9 %
Net Income 111.84 124.26 11.1 %
Average Shares 97.68 101.57 4.0 %
Earnings Per Share before unusual items (Riyal) 1.14 1.10 (3.9 %)
EPS (Riyal) 1.14 1.22 6.8 %

Net profit grew 11% in Q2 2025 to SAR 124.3 million from SAR 111.8 million in Q2 2024.

 

On a sequential basis, net profit fell 20.1% from SAR 155.56 million in Q1 2025.

 

Total shareholders’ equity, after minority interest, stood at SAR 4.13 billion by June 30, 2025, compared to SAR 3.37 billion a year earlier.

 

Attached Documents

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.